Brady Beltrán
About
In The Last Decade
Brady Beltrán
66 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Pathology and Forensic Medicine 761
- Oncology 757
- Immunology 259
- Neurology 186
- Genetics 182
Countries citing papers authored by Brady Beltrán
This map shows the geographic impact of Brady Beltrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brady Beltrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brady Beltrán more than expected).
Fields of papers citing papers by Brady Beltrán
This network shows the impact of papers produced by Brady Beltrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brady Beltrán. The network helps show where Brady Beltrán may publish in the future.
Co-authorship network of co-authors of Brady Beltrán
This figure shows the co-authorship network connecting the top 25 collaborators of Brady Beltrán. A scholar is included among the top collaborators of Brady Beltrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brady Beltrán. Brady Beltrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 15 | |
| 9 | 4 | |
| 10 | 0 | |
| 11 | Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma | 5 |
| 12 | 3 | |
| 13 | 13 | |
| 14 | 0 | |
| 15 | 37 | |
| 16 | 27 | |
| 17 | 2 | |
| 18 | 119 | |
| 19 | 6 | |
| 20 | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.